<DOC>
	<DOCNO>NCT00002252</DOCNO>
	<brief_summary>To determine efficacy safety Sandostatin ( octreotide ) compare placebo control diarrhea manifestation complication document HIV infection refractory ( respond ) know treatment class .</brief_summary>
	<brief_title>A Multicenter Placebo-Controlled Dose Titration Study Evaluate Efficacy Safety Sandostatin ( SMS 201-995 ) Treatment Patients With Acquired Immunodeficiency Related Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Inclusion Criteria Patients must follow : Uncontrolled diarrhea either manifestation complication document HIV infection . Ability communicate , participate , comply requirement study . Capability self administer injection study medication responsible family member companion . Given write consent prior study entry . Prior Medication : Required : At least two week conventional dose regimen antidiarrheal medication ( e.g . : Lomotil , Imodium , Paregoric ) within one month prior study entry . OR Patients evidence upper low GI infection ( ) approve , potentially curative therapy must fail appropriate treatment least two week . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Evidence underlie immunosuppressive disease due HIV . Diarrhea cause know gastrointestinal disorder idiopathic ulcerative colitis , Crohn 's disease , acute stool culture positive bacterial colitis ( document within last 2 week prior study entry AND least 2 week antibiotic therapy ) , pseudomembranous colitis ( Clostridium difficile toxin positive ) , short gut syndrome , chronic pancreatitis ( alcoholic idiopathic ) , ischemic bowel disease , enteroenteric fistula . Patients follow exclude : Diarrhea control conventional antidiarrheal agent . Stool weight either 2 baseline period average &lt; 500 g/day . Evidence underlie immunosuppressive disease due HIV . Diarrhea cause gastrointestinal disorder related HIV . Prior Medication : Excluded : Previously treat Sandostatin antidiarrheal agent . Experimental antidiarrheal drug within one month study entry . Present intravenous drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1992</verification_date>
	<keyword>Octreotide</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>